Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck
Cesar A. Perez, Hunho Song, Luis E. Raez, Mark Agulnik, Tatyana A. Grushko, Allison Dekker, Kerstin Stenson, Elizabeth A. Blair, Olufunmilayo I. Olopade, Tanguy Y. Seiwert, Everett E. Vokes, Ezra E.W. Cohen*
Dive into the research topics of 'Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck'. Together they form a unique fingerprint.